Limited success using the 'flare' protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization

Fertility and Sterility

Volumn 67, Issue 5, 1997, Pages 900-903

  Vishvanath, Karande ^a,b   Miller, Charles ^a   Morris, Randy ^a   Ramaa, Rao ^a   Rinehart, John ^a   Gleicher, Norbert ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Chicago Center for Human Reproduction   (United States)

Author keywords

'flare' protocol; basal follicle stimulating hormone; controlled ovarian hyperstimulation; In vitro fertilization; poor responders

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN CELL; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OOCYTE DONATION; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0343924407     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81403-3     Document Type: Article

References (16)

1. Speroff L, Glass RH, Kase NG, editors. Assisted reproduction. In: Clinical gynecologic endocrinology and infertility. 5th ed. Baltimore: Williams and Wilkins, 1994:931-46.
2. Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu H-C, et al. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298-307.
3. Scott RT Jr, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651-4.
4. Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-91.
5. Karande VC, Jones GS, Veeck LL, Muasher SJ. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. Fertil Steril 1990;53: 486-9.
6. Muasher SJ. Use of gonadotropin-releasing hormone agonists in controlled ovarian hyperstimulation for in vitro fertilization. Clin Ther 1992;14:74-86.
7. Owen EJ, Shoham Z, Mason BA, Ostergaard H, Jacobs HS. Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertil Steril 1991;56:1104-8.
8. Garcia JE, Padilla SL, Bayati J, Baramki TA. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Fertil Steril 1990;53:302-5.
9. Acharya U, Small J, Randall J, Hamilton M, Templeton A. Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilization program. Fertil Steril 1992;57:815-8.
10. Benadiva CA, Blasco L, Tureck R, Mastroianni L Jr., Flickinger GL. Comparison of different regimens of a gonadotropin-releasing hormone analog during ovarian stimulation for in vitro fertilization. Fertil Steril 1990;53:479-85.
11. San Roman GA, Surrey ES, Judd HL, Kerin JF. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril 1992;58:744-9.
12. Tan S-L, Kingsland C, Campbell S, Mills C, Bradfield J, Alexander N, et al. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810-4.
13. Scott RT Jr, Hofmann GE, Oehninger S, Muasher SJ. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;54:297-302.
14. Brown JR, Liu HC, Sewitch KF, Rosenwaks Z, Berkeley AS. Variability of day 3 follicle-stimulating hormone levels in eumenorrheic women. J Reprod Med 1995;40:620-4.
15. Hansen LM, Batzer FR, Gutmann JN, Corson SL, Kelly MP, Gocial B. Evaluating ovarian reserve: follicle stimulating hormone and oestradiol variability during cycle days 2-5. Hum Reprod 1996;11:486-9.
16. Licciardi FL, Liu H-C, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995;64:991-4.